Professor Libby Roughead

Research Professor UniSA Clinical & Health Sciences

City East Campus (P6-30)
tel +61 8 830 21238

email Libby.Roughead@unisa.edu.au

Alternative contact

Available for media comment
Research Degree Supervisor

About me

Libby Roughead is an NHMRC funded Senior Principal Research Fellow. Her research focuses on quantifying the extent of problems with medicines use, identifying the extent of adverse reactions to medicines, testing solutions for improving medicines use and evaluating improvements in health care.

Her research supports pharmaceutical policy development, she has expertise in developing and measuring performance indicators for evaluating pharmaceutical policy, including the development and measurement of performance indicators for quality use of medicines and the national medicines policy

She has extensive experience in drug utilisation and has been a member of Australia’s Drug Utilisation Subcommittee of the Pharmaceutical... Read more

UniSA Clinical & Health Sciences

UniSA Clinical & Health Sciences is addressing society’s most critical and emerging health needs through quality teaching, learning and research excellence.

Other UniSA associations

Quality Use of Medicines and Pharmacy Research Centre

Tweets by @UniversitySA

About me

In the media

Date	Title
20/11/2018	Improving Medication Safety, https://www.unisa.edu.au/EnterprisingResearchTalks/Talks/Libby-Roughead/
24/10/2014	Knowledge Works Seminar: Medication Safety; new challenges in the 21st century, https://www.youtube.com/watch?v=gexXGsUXOq0
26/09/2014	Successful Ageing Seminar: Are your pills making you ill?, https://lrs.unisa.edu.au/ess/echo/presentation/fcaee3c9-89ae-4c5d-ae4b-5134f55b9d4a/media.m4v

Research

Research themes

An age friendly world
Healthy futures
Transforming societies

Research focus

Public Health and Health Services
Clinical Sciences
Medical and Health Sciences
Pharmacology and Pharmaceutical Sciences
Policy and Administration

Highlights

Public policy concerning medicines
Quality Use of Medicines / Rational Drug Use
Pharmacoepidemiology
Pharmaceutical Promotion

Research

Projects

Excludes commercial-in-confidence projects.

Turning antimicrobial resistance in resid ential aged care inside-out from the patient to facility level, MRFF - Targeted Call for Research - Antimicrobial Resistance, 26/06/2018 - 31/05/2023
Large scale evidence generation for the utilisation and safety of biologic medicines, NHMRC - Project Grant, 01/01/2019 - 31/12/2022
Strengthening responses to dementia: Building an evidence platform for the development of a Vietnam National Dementia Plan, NHMRC-NAFOSTED Joint Call for Collaborative Research Projects, 01/04/2019 - 31/03/2022
Using Big Data to improve medication use and safety, NHMRC - Research Fellowship, 01/01/2016 - 31/12/2021
Establishment of a health data analytics panel, Cwth Dept of Health, 01/09/2016 - 08/12/2021
Veterans' Medicines Advice and Therapeutics Education Services (Veterans' MATES) Program, Cwth Dept of Veterans' Affairs, 01/09/2015 - 30/06/2021
ReMinDAR Trial: Reducing medicine induced deterioration and adverse reactions trial, Cwth Dept of Health, 15/09/2017 - 31/03/2021
CVC Mental Health Pilot, Cwth Dept of Veterans' Affairs, 03/01/2018 - 31/12/2020
Why is there an increased risk of severe adverse perinatal outcomes after the use of clomiphene citrate for infertility treatment?, NHMRC - Project Grant, 01/01/2018 - 31/12/2020
How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada the European Union and the United States, NHMRC - Project Grant, 01/01/2017 - 31/12/2020
Veterans' Medicines Advice and Therapeutics Education Services (Veterans' MATES) Program, Cwth Dept of Veterans' Affairs, 01/09/2015 - 18/12/2018
Centre of Research Excellence in post-market surveillance of medicines and medical devices, NHMRC - Centre of Research Excellence, 01/11/2012 - 31/10/2018
The provision of the Veterans' Medicines Advice and Therapeutics Education Service (Veterans' MATES), Cwth Dept of Veterans' Affairs, 10/07/2010 - 31/12/2016
RAMEMH Pilot Report National Survey Data Analysis, ACT Health, 06/06/2016 - 23/12/2016
Review of International Experiences & Good Practices on Pharmaceutical Manufacturing, Distribution, Purchasing and Pricing to Support China's Pharmaceutical Policy Development, Duke Kunshan University, 26/10/2015 - 28/02/2016
First step of WHO/EMP work for improving medicines use in countries, World Health Organisation Malaysia, 16/11/2015 - 12/02/2016
Scoping review of medical safety in mental health, Australian Council for Safety and Quality in Patient Healthcare, 15/12/2014 - 30/12/2015
Review of Australia atlas on health care variation, Australian Commission on Safety and Quality in Health Care, 16/09/2015 - 30/11/2015
Coverage with Evidence Development: Application to pharmaceutical reimbursement decisions, ARC - Future Fellowship, 15/03/2010 - 30/06/2014
Literature Review: Medication Safety in Australian 2008 - 2013, Cwth Dept of Health, 05/06/2008 - 30/06/2013

Other projects

Veterans' MATES

Research

Outputs

Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus

Open access indicates that an output is open access.

Highlights

Year	Output
2017	Roughead, EE, Pratt, NL, Kalisch Ellett, LM, Ramsay, EM, Barratt, JD, Morris, P & Killer, G 2017, 'Posttraumatic stress disorder, antipsychotic use and risk of dementia in veterans', Journal of the American Geriatrics Society, vol. 65, no. 7, pp. 1521-1526. Open access 9 10 10
2016	Shin, J-Y, Roughead, EE, Park, B-J & Pratt, NL 2016, 'Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study', BMJ: British Medical Journal, vol. 353, article no. i2550, pp. 1-8. Open access 51 49 267
2015	Roughead, EE, Chan, EW, Choi, N-K, Kimura, M, Kimura, T, Kubota, K, Lai, EC-C, Man, KK, Nguyen, TA, Ooba, N, Park, B-J, Sato, T, Shin, J-Y, Wang, T, Griffiths, J, Wong, IC, Yang, Y-HK & Pratt, N 2015, 'Variation in association between thiazolidinediones and heart failure across ethnic groups: retrospective analysis of large healthcare claims databases in six countries', Drug Safety, vol.38, no. 9, pp. 823-831. Open access 18 18 3
2015	Scott, IA, Hilmer, SN, Reeve, E, Potter, K, Le Couteur, D, Rigby, D, Gnjidic, D, Del Mar, CB, Roughead, L, Page, A, Jansen, J & Martin, JH 2015, 'Reducing inappropriate polypharmacy: the process of deprescribing', JAMA Internal Medicine, vol. 175, no. 5, pp. 827-834. Open access 557 492 577
2014	Kalisch Ellett, LM, Pratt, NL, Ramsay, EN, Barratt, JD & Roughead, EE 2014, 'Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia', Journal of the American Geriatrics Society, vol. 62, no. 10, pp. 1916-1922. Open access 67 56 11

Chapters

Year	Output
2018	Nguyen, TA & Roughead, E 2018, 'Strengths and weaknesses of pharmaceutical policy in relation to rational and responsible medicines use', in MI Ibrahim, A Wertheimer et al. (eds), Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions, Academic Press, US, ch. 15, pp. 247-262. 1
2017	Nguyen, TA, Vitry, A & Roughead, EE 2017, 'Pharmaceutical policy in Vietnam', in Z Babar (ed.), Pharmaceutical policy in countries with developing healthcare systems, 1st ed., ADIS - Springer International Publishing, Switzerland, ch. 5, pp. 75-94. 6
2015	Nguyen, TA & Roughead, E 2015, 'Pharmaceutical pricing policies in Vietnam', in Z Babar (ed.), Pharmaceutical prices in the 21st century, Springer International, Germany, ch. 18, pp. 321-342. 5
2015	Roughead, E & Gilbert, A 2015, 'Development, delivery and evaluation of implementation programmes', in M Elseviers et al. (eds), Drug utilization research: methods and applications, Wiley-Blackwell, US, ch. 46, pp. 468-476.
2015	Vitry, AI, Thai, L & Roughead, EE 2015, 'Pharmaceutical pricing policies in Australia', in ZUD Babar (ed.), Pharmaceutical prices in the 21st century, Springer, Germany, ch. 1, pp. 1-23. 4 3

Journal Articles

Year	Output
2020	Andrade, AQ, LeBlanc, VT, Kalisch-Ellett, LM, Pratt, NL, Moffat, A, Blacker, N, Westaway, K, Barratt, JD & Roughead, EE 2020, 'Determinants of usefulness in professional behaviour change interventions: observational study of a 15-year national program', BMJ Open, vol. 10, no. 10, pp. 1-8. Open access
2020	Kalisch Ellett, LM, Kemp-Casey, A, Kassie, GM, Pratt, NL & Roughead, EE 2020, 'Use of analgesics following rescheduling of codeine in Australia: an interrupted time series analysis in the veteran population', International Journal of Drug Policy, vol. 81, article no. 102767, pp. 1-7. 3
2020	Kalisch Ellett, LM, Pratt, NL, Nguyen, TA & Roughead, EE 2020, 'Use of health and support services by people living with dementia in the community setting', Australasian Journal on Ageing, online, pp. 1-9. 1 5
2020	Lim, R, Bereznicki, L, Corlis, M, Kalisch Ellett, LM, Kang, AC, Merlin, T, Parfitt, G, Pratt, NL, Rowett, D, Torode, S, Whitehouse, J, Andrade, AQ, Bilton, R, Cousins, J, Kelly, L, Schubert, C, Williams, M & Roughead, EE 2020, 'Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome', BMJ Open, vol. 10, no. 4, article no. e032851, pp. 1-9. Open access 1 1
2020	Man, KK, Shao, SC, Chaiyakunapruk, N, Dilokthornsakul, P, Kubota, K, Li, J, Ooba, N, Pratt, N, Pottegard, A, Rasmussen, L, Roughead, EE, Shin, JY, Su, CC, Wong, IC, Kao Yang, YH & Lai, ECC 2020, 'Metabolic events associated with the use of antipsychotics in children, adolescents and young adults: a multinational sequence symmetry study', European Child and Adolescent Psychiatry: Official Journal of the European Society for Child and Adolescent Psychiatry, online, pp. 1-22.
2020	Moffat, AK, Apajee, J, Pratt, NL, Blacker, N, Le, BVT & Roughead, EE 2020, 'Use of medicines associated with dry mouth and dental visits in an Australian cohort', Australian Dental Journal, online, pp. 1-19.
2020	Moffat, AK, Pratt, NL, Kalisch Ellett, LM, Ramsay, EN & Roughead, EE 2020, 'Comorbidities in an Australian sample of chronic and new opioid users', Journal of Opioid Management, vol. 16,no. 2, pp. 103-110.
2020	Moffat, AK, Westaway, KP, Apajee, J, Frank, O, Shute, R, Weston, C, Blacker, N, Le Blanc, VT, Kalisch Ellett, LM, Pratt, NL & Roughead, EE 2020, 'Impact of a patient-specific national programme aimed at increasing the use of emollient moisturisers to reduce the risk of skin tears: a longitudinal cohort study', BMJ Open, vol. 10, no. 10, article number e039579, pp. 1-6. Open access
2020	Parfitt, G, Post, D, Kalisch Ellett, L, Lim, R, Penington, A, Corlis, M & Roughead, E 2020, 'A cross-sectional assessment of the relationship between sedative medication and anticholinergic medication use and the movement behaviour of older adults living in residential aged care', PEERJ, vol. 8, no. e9605, pp. 1-9. Open access
2020	Seaman, KL, Sanfilippo, FM, Bulsara, MK, Brett, T, Kemp-Casey, A, Roughead, EE, Bulsara, C & Preen, DB 2020, 'Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase', Australian Health Review, vol. 44, pp. 377-384.
2020	Westaway, K, Sluggett, J, Alderman, C, Moffat, A, Procter, NG & Roughead, E 2020, 'The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: A literature review', Dementia: The International Journal of Social Research and Practice, vol. 19, no. 4, pp. 1189-1202. Open access 6 6 27
2020	Zhan, C, Roughead, E, Liu, L, Pratt, N & Li, J 2020, 'Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data', Journal of Biomedical Informatics, vol. 112, article no. 103603, pp. 1-13.
2020	Zhan, C, Roughead, E, Liu, L, Pratt, N & Li, J 2020, 'Detecting potential signals of adverse drug events from prescription data', Artificial Intelligence in Medicine, vol. 104, article no. 101839, pp. 1-14. 2
2019	Andrade, AQ & Roughead, EE 2019, 'Consumer-directed technologies to improve medication management and safety', Medical Journal of Australia, vol. 210, no. S6, pp. S24-S27. Open access 2 2 5
2019	Caughey, GE, Gadzhanova, S, Shakib, S & Roughead, EE 2019, 'Concomitant prescribing of opioids and benzodiazepines in Australia, 2012-2017', Medical Journal of Australia, vol. 210, no. 1, pp. 39-40. 3 3 2
2019	Caughey, GE, Shakib, S, Barratt, JD & Roughead, EE 2019, 'Use of medicines that may exacerbate heart failure in older adults: therapeutic complexity of multimorbidity', Drugs and Aging, vol. 36, no. 5, pp. 471-479. 2 2 2
2019	Duszynski, KM, Pratt, NL, Lynch, JW, Berry, JG, Gold, MS & Roughead, EE and 24 other authors and 1 consortium 2019, 'Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index.', Vaccine, vol. 37, no. 2, pp. 280-288. 15
2019	Gadzhanova, S, Gillam, M & Roughead, E 2019, 'Risk of falls and injuries requiring hospitalisation after first-eye cataract surgery in elderly Australians', Acta Ophthalmologica, vol. 98, no. 4, pp. e495-e498.
2019	Gillam, MH, Kerr, M, Pratt, NL, Lim, R & Roughead, EE 2019, 'Mesh use in urogynaecological procedures between 2005 and 2016: an Australian cohort study', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 59, no. 1, pp. 105-109. Open access 1 4
2019	Kalisch Ellett, LM, Kassie, GM, Pratt, NL, Kerr, M & Roughead, EE 2019, 'Prevalence and duration of use of medicines recommended for short-term use in aged care facility residents', Pharmacy, vol. 7, no. 2, pp. 1-11. Open access 2
2019	Kalisch Ellett, LM, Moffat, AK, Gadzhanova, S, Pratt, NL, Apajee, J, Woodward, M & Roughead, EE 2019, 'Reduction in use of risperidone for dementia in Australia following changed guidelines', Pharmacy, vol. 7, no. 3, pp. 1-11. Open access 1
2019	Kalisch Ellett, LM, Pratt, NL, Apajee, J & Roughead, EE 2019, 'Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission', International Journal of Clinical Pharmacy, vol. 41, no. 5, pp. 1341-1347. 1 1
2019	Kassie, GM, Kalisch Ellett, LM, Nguyen, TA & Roughead, EE 2019, 'Use of medicines that may precipitate delirium prior to hospitalisation in older Australians with delirium: an observational study', Australasian Journal on Ageing, vol. 38, no. 2, pp. 124-131. 22
2019	Kemp-Casey, A, Ceria-Pereña, J, Guerrero, AM, Suchonwanich, N, Salleh, SM & Roughead, EE 2019, 'Follow-up data on patent expiry and atorvastatin price: experiences in Brunei Darussalam, Malaysia, the Philippines and Thailand', WHO South-East Asia journal of public health, vol. 8, no. 2, pp. 115-117. 4
2019	Kemp-Casey, A, Pratt, N, Ramsay, E & Roughead, EE 2019, 'Using post-market utilisation analysis to support medicines pricing policy: an Australian case study of aflibercept and ranibizumab use', Applied Health Economics and Health Policy, vol. 17, no. 3, pp. 411-417. Open access 2 2 8
2019	Laba, TL, Jan, S, Zwar, NA, Roughead, E, Marks, GB, Flynn, AW, Goldman, MD, Heaney, A, Lembke, KA & Reddel, HK 2019, 'Cost-related underuse of medicines for asthma-opportunities for improving adherence', Journal of Allergy and Clinical Immunology-In Practice, vol. 7, no. 7, pp. 2298-2306.e12. Open access 7 5 9
2019	Laba, TL, Reddel, HK, Zwar, NJ, Marks, GB, Roughead, E, Flynn, A, Goldman, M, Heaney, A, Lembke, K & Jan, S 2019, 'Does a patient-directed financial incentive affect patient choices about controller medicines for asthma? A discrete choice experiment and financial impact analysis', PharmacoEconomics, vol. 37, pp. 227-238. Open access 1 1 2
2019	Lim, R, Kalisch Ellett, L, Widagdo, I, Pratt, N & Roughead, E 2019, 'Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: a cross-sectional study in Australia', BMJ Open, vol. 9, no. 9, pp. 1-9. Open access 2 1
2019	Moffat, AK, Pratt, NL, Kerr, M, Kalisch Ellett, LM & Roughead, EE 2019, 'Risk of chronic opioid use in older persons with pre-existing anxiety', Journal of Opioid Management, vol. 16, no. 1, pp. 59-66.
2019	Pratt, NL, Ramsay, E, Kalisch Ellett, LM, Duszynski, K, Shakib, S, Kerr, M, Caughey, G & Roughead, EE 2019, 'Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study', BMJ Open, vol.9, no. 5, article no. e026486, pp. 1-11. Open access 3 2
2019	Preiss, AK, Roughead, EE & Pratt, NL 2019, 'Sequence symmetry analysis graphic adjustment for prescribing trends', BMC Medical Research Methodology, vol. 19, no. 1, article no.143, pp. 1-12. Open access 1
2019	Rasmussen, L, Pratt, N, Roughead, E & Moffat, A 2019, 'Prevalence of psychotropic medicine use in Australian children with autism spectrum disorder: a drug utilization study based on children enrolled in the Longitudinal Study of Australian Children', Journal of Autism and Developmental Disorders, vol. 49, no. 1, pp. 227–235. 3 2 4
2019	Roughead, EE, Lim, R, Ramsay, E, Moffat, A & Pratt, N 2019, 'Persistence with opioids post discharge from hospitalisation for surgery in Australian adults: a retrospective cohort study', BMJ Open, vol. 9, no. 4, article no. e023990, pp. 1-6. Open access 11 10 30
2019	Roughead, EE, Nguyen, TA, Pham, T, Dang, TH, Hinton, WL, Nguyen, AT, Pham, TL, Crotty, M, Kurrle, S, Bui, QT & Nguyen, H 2019, 'Towards the development of Vietnam's national dementia plan--the first step of action', Australasian Journal on Ageing, online, pp. 1-5. 2 2
2019	Seaman, K, Sanfilippo, F, Bulsara, M, Roughead, L, Kemp-Casey, A, Bulsara, C, Watts, GF & Preen, D 2019, 'Predictors of ceasing or reducing statin medication following a large medication consumer co-payment increase: A retrospective observation study.', Public Health Research and Practice, online, pp. 1-13. Open access 3
2019	Tudball, J, Reddel, HK, Laba, TL, Jan, S, Flynn, A, Goldman, M, Lembke, K, Roughead, E, Marks, GB & Zwar, N 2019, 'General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: A qualitative study', Australian Health Review, vol. 43, no. 3, pp. 246-253. 3 2 1
2019	Westaway, K, Blacker, N, Shute, R, Allin, R, Elgebaly, Z, Frank, O, Pratt, N & Roughead, E 2019, 'Combination psychotropic medicine use in older adults and risk of hip fracture', Australian Prescriber, vol. 42, no. 3, pp. 93-96. Open access 92
2018	Bartlett, LE, Pratt, N & Roughead, EE 2018, 'Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?', Current Medical Research and Opinion, vol. 34, no. 2, pp. 305-311. 6 6 3
2018	Bartlett, LE, Pratt, NL & Roughead, EE 2018, 'Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts', Patient Preference and Adherence, vol. 12, pp. 835-843. Open access 1 1 1
2018	Gadzhanova, S, Roughead, E, Lowy, H & O'Connor, D 2018, 'Reducing adverse medication events in mental health: Australian National Survey', International Journal of Evidence-Based Healthcare, vol. 18, no. 1, pp. 108-115. 12
2018	Gadzhanova, S, Roughead, EE & Pont, LG 2018, 'Antidepressant switching patterns in the elderly', International Psychogeriatrics, vol. 30, no. 9, pp. 1365-1374. 7
2018	Gillam, MH, Inacio, MC, Pratt, NL, Shakib, S & Roughead, EE 2018, 'Magnetic resonance imaging in people with cardiac implantable electronic devices: a population based cohort study', Heart Lung and Circulation, vol. 27, pp. 748-751. Open access 3 1
2018	Gillam, MH, Pratt, NL, Inacio, MC, Shakib, S, Sanders, P, Lau, DH & Roughead, EE 2018, 'Rehospitalizations for complications and mortality following pacemaker implantation: a retrospective cohort study in an older population', Clinical Cardiology (Hoboken): An Indexed and Peer-Reviewed Journal for Advances in the Treatment of Cardiovascular Disease, vol. 41, no. 11, pp. 1480-1486. Open access 1 3 1
2018	Hoang, T, Liu, J, Pratt, N, Zheng, VW, Chang, KC, Roughead, E & Li, J 2018, 'Authenticity and credibility aware detection of adverse drug events from social media', International Journal of Medical Informatics, vol. 120, pp. 157-171. Open access 2 2 1
2018	Hoang, T, Liu, J, Roughead, E, Pratt, N & Li, J 2018, 'Supervised signal detection for adverse drug reactions in medication dispensing data', Computer Methods and Programs in Biomedicine, vol. 161, pp. 25-38. 6 6 2
2018	Inacio, M, Cashman, K, Pratt, N, Gillam, M, Caughey, G, Graves, S & Roughead, E 2018, 'Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients', Osteoarthritis and Cartilage, vol. 26, no. 3, pp. 356-362. Open access 13 13 1
2018	Kalisch Ellett, L, Pratt, N & Roughead, E 2018, 'Analgesic use in Vietnam veterans' with musculoskeletal pain', Journal of Military and Veterans Health, vol. 26, no. 3, pp. 28-35. Open access 1
2018	Kalisch Ellett, LM, Lim, R, Pratt, NL, Kerr, M, Ramsay, EN, Leblanc, T V, Barratt, JD & Roughead, EE 2018, 'Reducing hypnotic use in insomnia management among Australian veterans: Results from repeated national interventions', BMC Health Services Research, vol.18, no. 1, article no. 626, pp. 1-10. Open access 2 1 11
2018	Kalisch Ellett, LM, Pratt, NL, Kerr, M & Roughead, EE 2018, 'Antipsychotic polypharmacy in older Australians', International Psychogeriatrics, vol. 30, no. 4, pp. 539-546. Open access 1 1
2018	Kalisch Ellett, LM, Pratt, NL, Sluggett, JK, Ramsay, EN, Kerr, M, LeBlanc, VT, Barratt, JD, Gilbert, AL & Roughead, EE 2018, 'Sustaining practice change in health care: the impact of a national quality improvement program on the uptake of collaborative medicines reviews', Journal of Pharmacy Practice and Research, vol. 48, no. 3, pp. 222-230. Open access 2 14
2018	Kassie, GM, Nguyen, TA, Kalisch Ellett, LM, Pratt, NL & Roughead, EE 2018, 'Do risk prediction models for postoperative delirium consider patients' preoperative medication use?', Drugs and Aging, vol. 35, no. 3, pp. 213-222. 1 1 7
2018	Lai, EC-C, Shin, J-Y, Kubota, K, Man, KK, Park, BJ, Pratt, N, Roughead, EE, Wong, IC, Kao Yang, Y-H & Setoguchi, S 2018, 'Comparative safety of NSAIDs for gastrointestinal events in Asia-Pacific populations: a multi-database, international cohort study', Pharmacoepidemiology and Drug Safety, vol. 27, no. 11, pp. 1223-1230. Open access 1 1
2018	Lim, R, Kerr, M & Roughead, EE 2018, 'Use of medicines and health services for chronic obstructive pulmonary disease among a cohort of Australians over 50 years', International Journal Of Chronic Obstructive Pulmonary Disease, vol. 2018, no. 13, pp. 3085-3093. Open access 5
2018	Namba, RS, Inacio, MC, Pratt, NL, Graves, SE, Roughead, EE & Paxton, EW 2018, 'Persistent opioid use following total knee arthroplasty: a signal for close surveillance', Journal of Arthroplasty, vol. 33, no 2, pp. 331-336. 28 24 9
2018	Nguyen, TA, Knight, R, Mant, A, Razee, H, Brooks, G, Dang, TH & Roughead, EE 2018, 'Corruption practices in drug prescribing in Vietnam - an analysis based on qualitative interviews', BMC Health Services Research, vol. 18, no. 1, article no. 587, pp. 1-20. Open access 2 2 14
2018	Nguyen, TA, Pham, T, Vu, HTT, Nguyen, TX, Dang, HT, Kalisch-Ellett, L, Gillam, M, Pratt, N & Roughead, EE and 16 other authors 2018, 'Use of potentially inappropriate medications in people with dementia in Vietnam and its associated factors', American Journal of Alzheimer's Disease and Other Dementias, vol. 33, no. 7, pp. 423-432. Open access 2 2 9
2018	Poh, EW, McArthur, A, Stephenson, M & Roughead, EE 2018, 'Effects of pharmacist prescribing on patient outcomes in the hospital setting: A systematic review', The JBI Database of Systematic Reviews and Implementation Reports, vol. 16, no. 9, pp. 1823-1873. Open access 6 14
2018	Pratt, N & Roughead, E 2018, 'Assessment of medication safety using only dispensing data', Current Epidemiological Reports, vol. 5, no. 4, pp. 357-369. Open access 3
2018	Pratt, N, Kerr, M, Barratt, J, Kemp-Casey, A, Kalisch Ellett, L, Ramsay, E & Roughead, E 2018, 'The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System', BMJ Open, vol. 8, no. 4, pp. 1-8. Open access 41 41 5
2018	Raman, SR, Man, KK, Bahmanyar, S, Berard, A, Pratt, NL, Roughead, EE & Wong, IC and 26 other authors 2018, 'Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases', The Lancet Psychiatry, vol. 5, no. 10, pp. 824-835. Open access 58 56 140
2018	Robinson, MF, Mihalopoulos, C, Merlin, T & Roughead, E 2018, 'Characteristics of managed entry agreements in Australia', International Journal of Technology Assessment in Health Care, vol. 34, no. 1, pp. 46 - 55. 9 8
2018	Roughead, E, Kim, DS, Ong, B & Kemp-Casey, A 2018, 'Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price', WHO South-East Asia journal of public health, vol. 7, no. 2, pp. 99-106. 3
2018	Soleymani, F, Taheri, F, Roughead, E, Nikfar, S & Abdollahi, M 2018, 'Pattern of antidepressant utilization and cost in Iran from 2006 to 2013 in comparison with other countries', Journal of Epidemiology and Global Health, vol. 8, no. 3-4, pp. 213-219. Open access 1 1
2018	Sriskandarajah, S, Hobbs, J, Roughead, E, Ryan, M & Reynolds, K 2018, 'Safety and effectiveness of 'hospital in the home' and 'outpatient parenteral antimicrobial therapy' in different age groups: A systematic review of observational studies', International Journal of Clinical Practice, vol. 72, no. 8, article no. e13216, pp. 1-15. 7 7
2018	Westaway, K, Frank, O, Shute, R, Moffat, A, LeBlanc, V, Rowett, D, Blacker, N & Roughead, E 2018, 'Gathering tips from carers to support people with dementia: an adaptation of the TOP 5 program for community use', International Journal of Evidence-Based Healthcare, vol. 16, no. 2, pp. 128-135. Open access 1 1 1
2018	Widagdo, IS, Pratt, NL & Roughead, EE 2018, 'The association between frailty and medicines use over time: an analysis using the Australian Longitudinal Study on Ageing population', Journal of Pharmacy Practice and Research, vol. 48, no. 5, pp. 405-415. Open access 18
2018	Zhan, C, Roughead, E, Liu, L, Pratt, N & Li, J 2018, 'A data-driven method to detect adverse drug events from prescription data', Journal of Biomedical Informatics, vol. 85, pp. 10-20. 3 3 2
2017	Bartlett, L, Pratt, N & Roughead, EE 2017, 'Does tablet formulation alone improve adherence and persistence: A comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?', British Journal of Clinical Pharmacology, vol. 83, no. 1, pp. 202-210. Open access 9 8 2
2017	Caughey, GE, Pratt, NL, Barratt, JD, Shakib, S, Kemp-Casey, AR & Roughead, EE 2017, 'Understanding 30-day re-admission after hospitalisation of older patients for diabetes: identifying those at greatest risk', Medical Journal of Australia, vol. 206, no. 4, pp. 170-175. Open access 14 12 14
2017	Gadzhanova, S, Pratt, N & Roughead, E 2017, 'Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program', Diabetes Research and Clinical Practice, vol. 130, pp. 180-185. Open access 23 23 1
2017	Gillam, MH, Pratt, NL, Inacio, MC, Roughead, EE, Shakib, S, Nicholls, SJ & Graves, SE 2017, 'Heart failure after conventional metal-on-metal hip replacements: a retrospective cohort study', Acta Orthopaedica, vol. 88, no. 1, pp. 2-9. Open access 15 14 14
2017	Hansen, CA, Inacio, MC, Pratt, NL, Roughead, EE & Graves, SE 2017, 'Chronic use of opioids before and after total knee arthroplasty: a retrospective cohort study', Journal of Arthroplasty, vol. 32, no. 3, pp. 811-817.e1. 54 56 10
2017	Inacio, MC, Graves, SE, Pratt, NL, Roughead, EE & Nemes, S 2017, 'Increase in total joint arthroplasty projected from 2014 to 2046 in Australia: a conservative local model with international implications', Clinical Orthopaedics and Related Research, vol. 475, no. 8, pp. 2130-2137. Open access 51 47 11
2017	Kalisch Ellett, LM, Pratt, N, Sluggett, J, Ramsay, E, Kerr, M, LeBlanc, V, Barratt, J & Roughead, E 2017, 'Patient-specific prescriber feedback can increase the rate of osteoporosis screening and treatment: results from two national interventions', Archives of Osteoporosis, vol. 12, no. 1, article no. 17, pp. 1-7. Open access 3 3 3
2017	Kassie, GM, Kalisch Ellett, LM, Nguyen, TA & Roughead, E 2017, 'Current practice and opinions of hospital pharmacists regarding their role in the screening, prevention and treatment of delirium', International Journal of Clinical Pharmacy, vol. 39, no. 6, pp. 1194-1200. 4 3 13
2017	Kassie, GM, Kalisch Ellett, LM, Nguyen, TA & Roughead, EE 2017, 'Knowledge of Australian hospital pharmacists regarding delirium in elderly patients', Journal of Pharmacy Practice and Research, vol. 48, no. 2, pp. 116-123. 2 2
2017	Kassie, GM, Nguyen, TA, Kalisch Ellett, LM, Pratt, NL & Roughead, EE 2017, 'Preoperative medication use and postoperative delirium: a systematic review', BMC Geriatrics, vol. 17, article no. 298, pp. 1-10. Open access 19 17 14
2017	Kemp-Casey, A, Roughead, EE, Saunders, C, Boyle, F, Bulsara, M & Preen, DB 2017, 'Switching between endocrine therapies for primary breast cancer: frequency and timing in Australian clinical practice', Asia Pacific Journal of Clinical Oncology, vol 13, no. 2, pp. e161-e170. Open access 2 1
2017	Khalil, H & Roughead, L 2017, 'Medication safety programs in primary care: a scoping review protocol', The JBI Database of Systematic Reviews and Implementation Reports, vol. 15, no. 6, pp. 1512-1517.
2017	Khalil, H, Shahid, M & Roughead, L 2017, 'Medication safety programs in primary care: a scoping review', The JBI Database of Systematic Reviews and Implementation Reports, vol. 15, no.10, pp. 2512-2526. 2
2017	Kjosavik, SR, Gillam, MH & Roughead, EE 2017, 'Average duration of treatment with antipsychotics among concession card holders in Australia', Australian and New Zealand Journal of Psychiatry, vol. 51, no. 7, pp. 719-726. 1
2017	Leach, MJ, Pratt, NL & Roughead, EE 2017, 'Risk of hip fracture in older people using selective serotonin reuptake inhibitors and other psychoactive medicines concurrently: A matched case-control study in Australia', Drugs - Real World Outcomes, vol. 4, no. 2, pp. 87-96. Open access 4 6
2017	Leach, MJ, Pratt, NL & Roughead, EE 2017, 'The risk of hip fracture due to mirtazapine exposure when switching antidepressants or using other antidepressants as add-on therapy', Drugs - Real World Outcomes, vol. 4, no. 4, pp. 247-255. Open access 6 6
2017	Lopez, D, Kemp, CA, Saunders, C, Roughead, E, Boyle, F, Bulsara, M & Preen, D 2017, 'Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer', Public Health Research and Practice, vol. 27, no. 3, article no. e2731726, pp. 1-7. Open access 14
2017	Nguyen, TA, Knight, R, Mant, A, Razee, H, Brooks, G, Dang, TH & Roughead, EE 2017, 'Inflated medicine prices in Vietnam', Health Policy and Planning, vol. 32, pp. 647-656. Open access 5 5 9
2017	Pratt, N & Roughead, E 2017, 'Can we reduce the prevalence of persistent opioid use after surgery by predicting the future?', Anaesthesia and Intensive Care. 1 1
2017	Pratt, NL, Kalisch Ellett, LM, Sluggett, JK, Gadzhanova, S V, Ramsay, EN, Kerr, M, Leblanc, VT, Barratt, JD & Roughead, EE 2017, 'Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change', International Journal for Quality in Health Care, vol. 29, no. 1 pp. 75-82. Open access 13 12 18
2017	Roughead, EE, Pratt, NL, Kalisch Ellett, LM, Ramsay, EM, Barratt, JD, Morris, P & Killer, G 2017, 'Posttraumatic stress disorder, antipsychotic use and risk of dementia in veterans', Journal of the American Geriatrics Society, vol. 65, no. 7, pp. 1521-1526. Open access 9 10 10
2017	Seaman, KL, Sanfilippo, FM, Roughead, EE, Bulsara, MK, Kemp-Casey, A, Bulsara, C, Watts, GF & Preen, D 2017, 'Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia', BMJ Open, vol. 7, no. 6, article no. e013691, pp. 1-7. Open access 1 1 1
2016	Caughey, G, Barratt, J, Shakib, S, Kemp-Casey, A & Roughead, E 2016, 'Medication use and potentially high-risk prescribing in older patients hospitalized for diabetes: a missed opportunity to improve care?', Diabetic Medicine, online, pp.1- 8. 10 8 10
2016	Caughey, G, Vitry, A, Ramsay, E, Gilbert, A, Shakib, S, Ryan, P, Esterman, A, McDermott, R & Roughead, E 2016, 'Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes', Internal Medicine Journal, vol. 46, no. 12, pp. 1430-1436. Open access 6 7 29
2016	Gadzhanova, S & Roughead, E 2016, 'Prescribed antibiotic use in Australian children aged 0-12 years', Australian Family Physician, vol. 45, no. 3, pp. 134-138. Open access 5 5
2016	Gadzhanova, S, Roughead, EE & Bartlett, LE 2016, 'Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia', European Journal of Clinical Pharmacology, vol. 72, no. 6, pp. 765-771. Open access 7 7
2016	Hoang, T, Liu, J, Pratt, N, Zheng, VW, Chang, KC, Roughead, E & Li, J 2016, 'Detecting signals of detrimental prescribing cascades from social media', Artificial Intelligence in Medicine, vol. 71, pp. 43-56. 7 7 3
2016	Inacio, M, Pratt, N & Roughead, E 2016, 'Evaluation of three co-morbidity measures to predict mortality in patients undergoing total joint arthroplasty', Osteoarthritis and Cartilage, vol. 4, no. 10, pp. 1718-1726. Open access 12 9
2016	Inacio, M, Pratt, N, Roughead, E & Graves, S 2016, 'Response to Letter to the Editor: 'use of preoperative comorbidity scores to predict mortality after total arthroplasty'', Osteoarthritis and Cartilage, vol. 25, no. 1, pp. e7. Open access
2016	Inacio, MC, Hansen, C, Pratt, NL, Graves, SE & Roughead, EE 2016, 'Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study', BMJ Open, vol. 6, no. 4, article no. e010664, pp. 1-10. Open access 84 87 1
2016	Inacio, MC, Pratt, NL, Roughead, EE, Paxton, EW & Graves, SE 2016, 'Opioid use after total hip arthroplasty surgery is associated with revision surgery', BMC Musculoskeletal Disorders, vol. 17, article no. 122, pp. 1-9. Open access 23 21 17
2016	Kalisch Ellett, L, Pratt, N, Le, BV, Westaway, K & Roughead, E 2016, 'Increased risk of hospital admission for dehydration or heat-related illness after initiation of medicines: a sequence symmetry analysis', Journal of Clinical Pharmacy and Therapeutics, vol. 41, pp. 503-507. 11 7 25
2016	Kalisch Ellett, LM, Pratt, NL, Ramsay, EN, Sluggett, JK, Barratt, JD & Roughead, EE 2016, 'Central nervous system-acting medicines and risk of hospital admission for confusion, delirium, or dementia', Journal of the American Medical Directors Association, vol. 17, no. 6, pp. 530-534. 4 4 7
2016	Kemp, CA, Roughead, EE, Saunders, C, Boyle, F, Lopez, D, Bulsara, M & Preen, DB 2016, 'Breast cancer recurrence following active treatment: determining its incidence in the NSW population', Public Health Research and Practice, vol. 26, no.1, article no. e2611607, pp. 1-8. Open access 2 2 1
2016	Kjosavik, SR, Gillam, MH & Roughead, EE 2016, 'Average duration of treatment with antidepressants among concession card holders in Australia', Australian and New Zealand Journal of Psychiatry, vol. 50, no. 12, pp. 1180-1185. 2 1 1
2016	Namba, RS, Inacio, MC, Pratt, NL, Graves, SE, Roughead, EE, Cheetham, TC & Paxton, EW 2016, 'Postoperative opioid use as an early indication of total hip arthroplasty failure', Acta Orthopaedica, vol. 87, supplement 1, pp. 37-43. Open access 24 24
2016	Pratt, N, Ramsay, E, Caughey, GE, Shakib, S & Roughead, EE 2016, 'Uptake of novel oral anticoagulants in Australia', Medical Journal of Australia, vol. 204, pp. 104-105. Open access 25 14 1
2016	Roughead, EE, Chan, EW, Choi, N-K, Griffiths, J, Jin, X-M, Lee, J, Kimura, M, Kimura, T, Kubota, K, Lai, EC-C, Man, KK, Nguyen, TA, Ooba, N, Park, B-J, Sato, T, Shin, J-Y, Wang, T, Wong, IC, Yang, Y-HK & Pratt, NL 2016, 'Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis', Expert Opinion on Drug Safety, vol. 15, no. 12, pp. 1589-1595. Open access 16 16 4
2016	Roughead, EE, Semple, SJ & Rosenfeld, E 2016, 'The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia', International Journal of Evidence-Based Healthcare, vol. 14, no. 3, pp. 113-122. Open access 47 38 10
2016	Shin, H-Y, Gadzhanova, S, Roughead, EE, Ward, MB & Pont, LG 2016, 'The use of antipsychotics among people treated with medications for dementia in residential aged care facilities', International Psychogeriatrics, vol. 28, no. 6, pp. 977-982. 7 8 3
2016	Shin, J-Y, Roughead, EE, Park, B-J & Pratt, NL 2016, 'Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study', BMJ: British Medical Journal, vol. 353, article no. i2550, pp. 1-8. Open access 51 49 267
2016	Wahab, IA, Pratt, NL, Kalisch Ellett, L & Roughead, EE 2016, 'Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims database', Drug Safety, vol. 39, no. 4, pp. 347-354. 12 13
2016	Westaway, K, Sluggett, JK, Alderman, C, Procter, N & Roughead, E 2016, 'Prevalence of multiple antipsychotic use and associated adverse effects in Australians with mental illness', International Journal of Evidence-Based Healthcare, vol. 14, no. 3, pp. 104-112. Open access 9 10 5
2016	Widagdo, I, Pratt, N, Russell, M & Roughead, E 2016, 'Construct validity of four frailty measures in an older Australian population: a Rasch analysis', The Journal of Frailty and Aging, vol. 5, no. 2, pp. 78-81. Open access 2 9
2015	Caughey, GE, Kalisch Ellett, LM, Goldstein, S & Roughead, EE 2015, 'Suboptimal medication-related quality of care preceding hospitalisation of older patients', Medical Journal of Australia, vol. 203, no. 5, pp. 220.e1-220.e7. Open access 4 4 7
2015	Gadzhanova, S & Roughead, E 2015, 'Survival after initiation of androgen deprivation therapy for prostate cancer of Australian men', Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention, vol. 39, no. 6, pp. 854-859. 2 1
2015	Gadzhanova, S & Roughead, E 2015, 'Use of prescription medicines in Australian women of child-bearing age', BMC Pharmacology and Toxicology, vol. 16, article no. 33, pp. 1-12. Open access 5 3
2015	Gadzhanova, S, Roughead, E & Robinson, M 2015, 'Use of medicines with anticholinergic and sedative effect before and after initiation of anti-dementia medications', Drugs - Real World Outcomes, vol. 2, no. 1, pp. 53-60. Open access 9
2015	Gadzhanova, S, Roughead, EE & Pont, LG 2015, 'Safety of opioid patch initiation in Australian residential aged care', Medical Journal of Australia, vol. 203, no. 7, pp. 298.e1-298.e6. Open access 6 2 4
2015	Inacio, MC, Pratt, NL, Roughead, EE & Graves, SE 2015, 'Predicting infections after total joint arthroplasty using a prescription based comorbidity measure', Journal of Arthroplasty, vol. 30, no. 10, pp. 1692-1698. Open access 4 3
2015	Inacio, MCS, Pratt, NL, Roughead, EE & Graves, SE 2015, 'Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson measures: a cross-sectional evaluation', BMC Musculoskeletal Disorders, vol. 16, no. 1, article no. 385. Open access 9 10 2
2015	Inacio, MCS, Pratt, NL, Roughead, EE & Graves, SE 2015, 'Using medications for prediction of revision after total joint arthroplasty', Journal of Arthroplasty, vol. 30, no. 12, pp. 2061-2070. 5 4 1
2015	Kalisch Ellett, LM, Pratt, NL, Ramsay, EN, Barratt, JD & Roughead, EE 2015, 'Response to lertxundi and colleagues', Journal of the American Geriatrics Society, vol. 63, no. 5, pp. 1054-1055.
2015	Lai, EC-C, Man, KK, Chaiyakunapruk, N, Cheng, C-L, Pratt, N, Roughead, L & Setoguchi, S and 16 other authors 2015, 'Databases in the Asia-Pacific region: the potential for a distributed network approach', Epidemiology, 26, no. 6, pp. 815-820. Open access 30 31
2015	Nguyen, T, Caughey, G, Pratt, N, Shakib, S, Kemp, A & Roughead, E 2015, 'Hospitalization for drug-induced hepatotoxicity : linking Y-codes with pharmaceutical claims data to identify implicated medicines', Journal of Clinical Pharmacy and Therapeutics, vol. 40, no. 2, pp. 213-219. 1 1 2
2015	Othman, N, Vitry, A I, Roughead, EE, Ismail, SB & Omar, K 2015, 'Doctors' views on the quality of claims provided by pharmaceutical representatives: a comparative study in Malaysia and Australia', Journal of Taibah University Medical Sciences, vol. 10, no. 4, pp. 471-480. Open access 1 1 7
2015	Poh, EW, McArthur, A & Roughead, L 2015, 'The effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review protocol', The JBI Database of Systematic Reviews and Implementation Reports, vol. 13, no. 12, pp. 3-13. Open access
2015	Pratt, N, Chan, EW, Choi, N-K, Kimura, M, Kimura, T, Kubota, K, Lai, EC-C, Man, KK, Ooba, N, Park, B-J, Sato, T, Shin, J-Y, Wong, IC, Kao, YY-H & Roughead, EE 2015, 'Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries', Pharmacoepidemiology and Drug Safety, vol. 24, no. 8, pp. 858-864. Open access 10 22 5
2015	Pratt, NL, Kalisch Ellett, LM, Sluggett, JK, Ramsay, EN, Kerr, M, LeBlanc, VT, Barratt, JD & Roughead, EE 2015, 'Commitment questions targeting patients promotes uptake of under-used health services: findings from a national quality improvement program in Australia', Social Science and Medicine, vol. 145, pp. 1-6. 3 3 1
2015	Pratt, NL, Ramsay, EN, Kalisch Ellett, LM, Nguyen, TA & Roughead, EE 2015, 'Association between ophthalmic timolol and hospitalisation for bradycardia', Journal of Ophthalmology, vol. 2015, article no. 567387, pp. 1-6. Open access 11 9 10
2015	Roughead, EE & Pratt, NL 2015, 'Impact on drug safety of variation in adherence: the need for routinely reporting measures of dose intensity in medication safety studies using electronic health data', Drug Safety, vol. 38, no. 12, pp. 1145-1152. Open access 1
2015	Roughead, EE, Chan, EW, Choi, N-K, Kimura, M, Kimura, T, Kubota, K, Lai, EC-C, Man, KK, Nguyen, TA, Ooba, N, Park, B-J, Sato, T, Shin, J-Y, Wang, T, Griffiths, J, Wong, IC, Yang, Y-HK & Pratt, N 2015, 'Variation in association between thiazolidinediones and heart failure across ethnic groups: retrospective analysis of large healthcare claims databases in six countries', Drug Safety, vol.38, no. 9, pp. 823-831. Open access 18 18 3
2015	Scott, IA, Hilmer, SN, Reeve, E, Potter, K, Le Couteur, D, Rigby, D, Gnjidic, D, Del Mar, CB, Roughead, L, Page, A, Jansen, J & Martin, JH 2015, 'Reducing inappropriate polypharmacy: the process of deprescribing', JAMA Internal Medicine, vol. 175, no. 5, pp. 827-834. Open access 557 492 577
2015	Vitry, A, Nguyen, T, Entwistle, V & Roughead, E 2015, 'Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study', Journal of Pharmaceutical Policy and Practice, vol. 8, no. 25, pp. 1-11. Open access 7 10
2015	Widagdo, I, Pratt, N, Russell, M & Roughead, L 2015, 'How common is frailty in older Australians?', Australasian Journal on Ageing, vol. 34, no. 4, pp. 247-251. 9 7
2015	Widagdo, IS, Pratt, N, Russell, M & Roughead, EE 2015, 'Predictive performance of four frailty measures in an older Australian population', Age and Ageing, vol. 44, no. 6, pp. 967-972. Open access 16 18 3
2014	Gadzhanova, S & Roughead, E 2014, 'Co-prescribing of warfarin with statins and Proton Pump Inhibitors in elderly Australians', Advances in Pharmacoepidemiology & Drug Safety, vol. 3, no. 3, pp. 1-4. Open access
2014	Gadzhanova, S, Roughead, E & Ilomaki, J 2014, 'Use of statins in an Australian elderly population', International Journal of Clinical Cardiology, vol. 1, no. 3, article no. 016, pp. 1-4. Open access
2014	Kalisch Ellett, LM, Pratt, NL, Barratt, JD, Rowett, D & Roughead, EE 2014, 'Risk of medication-associated initiation of oxybutynin in elderly men and women', Journal of the American Geriatrics Society, vol. 62, no. 4, pp. 690-695. Open access 12 13 5
2014	Kalisch Ellett, LM, Pratt, NL, Ramsay, EN, Barratt, JD & Roughead, EE 2014, 'Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia', Journal of the American Geriatrics Society, vol. 62, no. 10, pp. 1916-1922. Open access 67 56 11
2014	Kemp, A, Preen, DB, Saunders, C, Boyle, F, Bulsara, M, Holman, CDJ, Malacova, E & Roughead, EE 2014, 'Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: the impact of comorbidity and demographics on initial choice', PLoS One, vol. 9, no. 1, article no. e84835, pp. 1-8. Open access 4 3 1
2014	Kemp, A, Preen, DB, Saunders, C, Boyle, F, Bulsara, M, Malacova, E & Roughead, EE 2014, 'Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?', SpringerPlus, vol. 3, paper no. 282, pp. 1-10. Open access 27 26 24
2014	Nguyen, TA, Knight, R, Roughead, EE, Brooks, G & Mant, A 2014, 'Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries', Health Policy and Planning, vol. 30, no. 2, pp. 267-280. Open access 44 33 18
2014	Pratt, NL, Ilomäki, J, Raymond, C & Roughead, EE 2014, 'The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines : a simulation study', BMC Medical Research Methodology, vol. 14, article no. 66. Open access 20 18 1
2014	Pratt, NL, Ramsay, EN, Kalisch Ellett, LM, Nguyen, TA, Barratt, JD & Roughead, EE 2014, 'Association between use of multiple psychoactive medicines and hospitalization for falls : retrospective analysis of a large healthcare claim database', Drug Safety, vol. 37, no. 7, pp. 529-535. Open access 23 21 13
2014	Pratt, NL, Ramsay, EN, Kemp, A, Kalisch Ellett, LM, SHAKIB, S, Caughey, GE, Ryan, P, Graves, S & Roughead, EE 2014, 'Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration : a self-controlled case-series analysis', Drug Safety, 37, no. 12, pp. 1021-1027. Open access 14 9 1
2014	Vitry, A & Roughead, E 2014, 'Managed entry agreements for pharmaceuticals in Australia', Health Policy, vol. 117, no. 3, pp. 345-352. 21 29 7
2014	Vitry, AI, Nguyen, TA, Ramsay, EN, Caughey, GE, Gilbert, AL, Shakib, S, Ryan, P, Esterman, AJ, McDermott, RA & Roughead, EE 2014, 'General practitioner management plans delaying time to next potentially preventable hospitalization for patients with heart failure', Internal Medicine Journal, vol. 44, no. 11, pp. 1117-1123. Open access 10 9 7
2014	Wahab, IA, Pratt, NL, Kalisch, LM & Roughead, EE 2014, 'Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database : a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia', Drug Safety, vol. 37, no. 1, pp. 53-64. 18 18 2
2013	Anderson, M, Bergman, U, Choi, N-K, Gerhard, T, Huang, C, Jalbert, J, Kimura, M, Kimura, T, Kubota, K, Lai, EC-C, Ooba, N, Park, B-J, Pratt, N, Roughead, EE, Sato, T, Setoguchi, S, Shin, J-Y, Sundstrom, A & Yang, Y-HK 2013, 'The Asian Pharmacoepidemiology Network (AsPEN) : promoting multi-national collaboration for pharmacoepidemiologic research in Asia', Pharmacoepidemiology and Drug Safety, vol. 22, no. 7, pp. 700-704. 36 36 4
2013	Caughey, GE, Preiss, A, Vitry, AI, Gilbert, AL & Roughead, EE 2013, 'Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications', Diabetes Care, vol. 36, no. 10, pp. 3009-3014. Open access 33 32 14
2013	Caughey, GE, Preiss, AK, Vitry, A I, Gilbert, AL, Ryan, P, Shakib, S, Esterman, A, McDermott, RA & Roughead, EE 2013, 'Does antidepressant medication use affect persistence with diabetes medicines?', Pharmacoepidemiology and Drug Safety, vol. 22, no. 6, pp. 615-622. Open access 12 11 6
2013	Gadzhanova, S V, Roughead, EE & Bartlett, MJ 2013, 'Improving cardiovascular disease management in Australia : NPS MedicineWise', Medical Journal of Australia, vol. 199, no. 3, pp. 192-195. Open access 7 7
2013	Gadzhanova, S, Bell, JS & Roughead, EE 2013, 'What analgesics do older people use prior to initiating oxycodone for non-cancer pain?: a retrospective database study', Drugs and Aging, vol. 30, no. 11, pp. 921-926. 14 14 2
2013	Gadzhanova, S, Ilomäki, J & Roughead, EE 2013, 'Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study', International Journal of Clinical Pharmacy, vol. 35, no. 4, pp 613-620. Open access 5 5
2013	Kalisch Ellett, LM, Ramsay, EN, Barratt, JD, Gilbert, AL & Roughead, EE 2013, 'Home medicines reviews: extent of uptake by high-risk veterans', Journal of Pharmacy Practice and Research, vol. 43, no. 3, pp. 182-186. 6
2013	Kemp, A, Preen, D, Glover, J, Semmens, J & Roughead, EE 2013, 'Impact of cost of medicines for chronic conditions on low income households in Australia', Journal of Health Services Research and Policy, vol. 18, no. 1, pp. 21-27. Open access 15 16 29
2013	Kemp, A, Preen, D, Saunders, C, Holman, D, Bulsara, M, Rogers, K & Roughead, EE 2013, 'Ascertaining invasive breast cancer cases : the validity of administrative and self-reported data sources in Australia', BMC Medical Research Methodology, vol. 13, article no. 17, pp. 1-8. Open access 19 19 1
2013	Leach, MJ, Pratt, NL & Roughead, EE 2013, 'Medicine use among older Australians before and after hip fracture', Journal of Pharmacy Practice and Research, vol. 43, no. 4, pp. 265-268. 4 6
2013	Pratt, N, Andersen, M, Bergman, U, Choi, N-K, Gerhard, T, Huang, C, Kimura, M, Kimura, T, Kubota, K, Lai, EC-C, Ooba, N, Osby, U, Park, B-J, Sato, T, Shin, J-Y, Sundstrom, A, Yang, Y-HK & Roughead, EE 2013, 'Multi-country rapid adverse drug event assessment : the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study', Pharmacoepidemiology and Drug Safety, vol. 22, no. 8, pp. 915-924. 33 29 4
2013	Ramsay, EN, Pratt, NL, Ryan, P & Roughead, EE 2013, 'Proton pump inhibitors and the risk of pneumonia : a comparison of cohort and self-controlled case series designs', BMC Medical Research Methodology, vol. 13, article no. 82, pp. 1-7. Open access 21 19 19
2013	Roughead, EE, Kalisch Ellett, LM, Ramsay, EN, Pratt, NL, Barratt, JD, Le, BVT, Ryan, P, Peck, R, Killer, G & Gilbert, AL 2013, 'Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans', BMC Health Services Research, vol. 13, article no. 514, pp. 1-14. Open access 23 21 4
2013	Roughead, EE, Lhazeen, K, Socialine, E, Bahri, S, Park, B & Holloway, K 2013, 'Monitoring medicines use to support national medicines policy development and implementation in the Asia Pacific region', WHO South-East Asia journal of public health, vol. 2, no. 2, pp. 113-117. Open access 3
2013	Sluggett, JK, Caughey, GE, Ward, MB, Roughead, EE & Gilbert, AL 2013, 'Transient ischaemic attack and ischaemic stroke : constructing episodes of care using hospital claims data', BMC Research Notes, vol. 6, article no. 128, pp. 1-6. Open access 7 1
2013	Wahab, IA, Pratt, NL, Kalisch Ellett, LM & Roughead, EE 2013, 'Sequence symmetry analysis and disproportionality analyses: what percentage of adverse drug reaction do they signal?', Advances in Pharmacoepidemiology & Drug Safety, vol. 2, no. 4, pp. 1-5. Open access
2013	Wahab, IA, Pratt, NL, Kalisch Ellett, LM & Roughead, EE 2013, 'The detection of adverse events in randomized clinical trials : can we really say new medicines are safe?', Current Drug Safety, vol. 8, no. 2, pp. 104-113. 8 1
2013	Wahab, IA, Pratt, NL, Wiese, MD, Kalisch, LM & Roughead, EE 2013, 'The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection', Pharmacoepidemiology and Drug Safety, vol. 22, no. 5, pp. 496-502. 36 37 4
2012	Clark, A & Roughead, L 2012, 'Pharmacists perspective on managing older patients with multiple chronic conditions', Australian Pharmacist, vol. 31, no. 2, pp. 148-150. Open access
2012	Gadzhanova, S, Ilomaki, J & Roughead, EE 2012, 'COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database study', Drugs and Aging, vol. 30, pp. 23-30. 5 5
2012	Kalisch Ellett, LM, Caughey, GE, Barratt, JD, Ramsay, EN, Killer, G, Gilbert, AL & Roughead, EE 2012, 'Prevalence of preventable medication-related hospitalizations in Australia : an opportunity to reduce harm', International Journal for Quality in Health Care, vol. 24, no. 3, pp. 239-249. Open access 45 37 2
2012	Kemp, A, Glover, J, Preen, D, Bulsara, M, Semmens, J & Roughead, EE 2012, 'From the city to the bush : increases in patient co-payments for medicines have impacted on medicine use across Australia', Australian Health Review, vol. 37, pp. 4-10. Open access 10 10 5
2012	Lu, C & Roughead, EE 2012, 'New users of antidepressant medications: first episode duration and predictors of discontinuation', European Journal of Clinical Pharmacology, vol. 68, no. 1, pp. 65-71. 23 23
2012	Ostini, R, Roughead, EE, Kirkpatrick, CM, Monteith, GR & Tett, SE 2012, 'Quality use of medicines: medication safety issues in naming; look-alike, sound-alike medicine names', International Journal of Pharmacy Practice, vol. 20, no. 6, pp. 349-357. Open access 24 1
2012	Pratt, NL, Roughead, EE, Salter, A & Ryan, P 2012, 'Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review', BMC Medical Research Methodology, vol. 12, article no. 72, pp. 1-19. Open access 36 34 1
2012	Roughead, EE, Kalisch Ellett, LM, Pratt, NL, Killer, G, Barnard, A & Gilbert, AL 2012, 'Managing glaucoma in those with co-morbidity : not as easy as it seems', Ophthalmic Epidemiology, vol. 19, no. 2, pp. 74-82. 19 17 1
2012	Vitry, A I, Roughead, EE, Ramsay, EN, Ryan, P, Caughey, GE, Esterman, A, Shakib, S, Gilbert, AL & McDermott, R 2012, 'Chronic disease management: does the disease affect likelihood of care planning?', Australian Health Review, vol. 36, no. 4, pp. 419-423. 5 5
2011	Bell, JS, Kalisch Ellett, LM, Ramsay, EN, Pratt, NL, Barratt, JD, Le, BT, Roughead, EE & Gilbert, AL 2011, 'Prescriber feedback to improve quality use of medicines among older people: the veterans' MATES program', Journal of Pharmacy Practice and Research, vol. 41, no. 4, pp. 316-319. Open access 11 3
2011	Caughey, GE, Roughead, EE, Pratt, NL, Killer, G & Gilbert, AL 2011, 'Stroke risk and NSAIDs: an Australian population-based study', Medical Journal of Australia, vol. 195, no. 9, pp. 525-529. Open access 42 36
2011	Caughey, GE, Roughead, EE, SHAKIB, S, Vitry, AI & Gilbert, AL 2011, 'Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data', Drugs and Aging, vol. 28, no. 7, pp. 575-581. 28 20
2011	Chanjaruporn, F, Roughead, EE, Sooksriwong, C-o & Kaojarem, S 2011, 'Budget impact analysis of pemetrexed introduction : case study from a teaching hospital perspective, Thailand', Journal of the Medical Association of Thailand, vol. 94, no. 9, pp. 1026-1034. 4
2011	Gadzhanova, S, Roughead, E & Mackson, J 2011, 'Initiation and duration of proton pump inhibitors in the Australian veteran population', Internal Medicine Journal, vol. 42, no. 5, pp. e68-e73. 12 8
2011	Gadzhanova, S, Roughead, EE, Loukas, K & Vajda, J 2011, 'Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs', Pharmacoepidemiology and Drug Safety, vol. 20, no. 4, pp. 359-365. 3 3
2011	Gadzhanova, SV, Gillies, M, Roughead, EE & Zuo, Y 2011, 'Fixed dose combination diabetes medicines: usage in the Australian veteran population', Australian Family Physician, vol. 40, no. 10, pp. 811-815. 4 3
2011	Gilbert, AL, Caughey, GE, Vitry, AI, Clark, AB, Ryan, P, McDermott, RA, SHAKIB, S, Luszcz, M, Esterman, AJ & Roughead, EE 2011, 'Ageing well: improving the management of patients with multiple chronic health problems', Australasian Journal on Ageing, vol. 30, no. S2, pp. 32-37. 16 17 3
2011	Kalisch Ellett, LM, Caughey, GE, Roughead, EE & Gilbert, AL 2011, 'The prescribing cascade', Australian Prescriber, vol. 34, no. 6, pp. 162-166. Open access 46 34
2011	Kemp, A, Preen, D, Glover, J, Semmens, J & Roughead, E 2011, 'How much do we spend on prescription medicines? Out of pocket costs for patients in Australia and other OECD countries', Australian Health Review, vol. 35, no. 3, pp. 341-349. Open access 14 15 3
2011	Kemp, A, Preen, DB, Sanfilippo, FM, Glover, J, Semmens, J & Roughead, EE 2011, 'Evaluating pharmaceutical policy impacts using interrupted time series analysis: an Australian case study', International Public Health Journal, vol. 3, no. 2, pp. 229-241.
2011	Lu, C & Roughead, E 2011, 'Determinants of patient-reported medication errors : a comparison among seven countries', International Journal of Clinical Practice, vol. 65, no. 7, pp. 733-740. Open access 25 23 19
2011	Lu, CY, Barratt, J, Vitry, A & Roughead, E 2011, 'Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting', Journal of Clinical Epidemiology, vol. 64, no. 2, pp. 223-228. 53 50 3
2011	Pratt, N, Roughead, EE, Ramsay, E, Salter, A & Ryan, P 2011, 'Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: a self-controlled case-series analysis in an Australian health care claims database', Drug Safety, vol. 34, no. 7, pp. 567-575. 55 49 1
2011	Ramsay, EN, Roughead, EE, Ewald, B, Pratt, N & Ryan, P 2011, 'A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly', BMC Medical Research Methodology, vol. 11, article no. 106. Open access 5 5
2011	Roughead, E, Kalisch, L, Ramsay, E, Ryan, P & Gilbert, A 2011, 'Continuity of care: when do patients visit community healthcare providers after leaving hospital?', Internal Medicine Journal, vol. 41, no. 9, pp. 662-667. 27 26
2011	Roughead, EE, Vitry, A I, Caughey, GE & Gilbert, AL 2011, 'Multimorbidity, care complexity and prescribing for the elderly', Aging Health, vol. 7, no. 5, pp. 695-705. 20 1
2011	Vitry, A I, Roughead, EE, Ramsay, EN, Preiss, AK, Ryan, P, Gilbert, AL, Caughey, GE, Shakib, S, Esterman, A, Zhang, Y & McDermott, RA 2011, 'Major bleeding risk associated with warfarin and co-medications in the elderly population', Pharmacoepidemiology and Drug Safety, vol. 20, no. 10, pp. 1057-1063. 41 35 1
2011	Zhang, Y, Vitry, A, Caughey, G, Roughead, EE, Ryan, P, Gilbert, A, Shakib, S & McDermott, R 2011, 'The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes', Diabetes Research and Clinical Practice, vol. 91, no. 1, pp. 115-120. 4 3 3
2010	Caughey, GE, Ramsay, E, Vitry, AI, Gilbert, AL, Luszcz, M, Ryan, P & Roughead, EE 2010, 'Comorbid chronic diseases, discordant impact on mortality in the elderly; a 14 year longitudinal population study', Journal of Epidemiology and Community Health, vol. 64, no. 12, pp. 1036-1042. Open access 41 33
2010	Caughey, GE, Roughead, EE, Pratt, N, Shakib, S, Vitry, A I & Gilbert, AL 2010, 'Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?', Pharmacoepidemiology and Drug Safety, vol. 19, no. 9, pp. 977-982. 34 30
2010	Caughey, GE, Roughead, EE, Shakib, S, McDermott, RA, Vitry, A I & Gilbert, AL 2010, 'Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants', Age and Ageing, vol. 39, no. 4, pp. 488-494. Open access 38 33
2010	Caughey, GE, Roughead, EE, Vitry, AI, McDermott, RA, Shakib, S & Gilbert, AL 2010, 'Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts', Diabetes Research and Clinical Practice, vol. 87, no. 3, pp. 385-393. 108 92
2010	Gadzhanova, SV, Roughead, EE & Mackson, J 2010, 'Anticholinesterase duration in the Australian veteran population', Australian and New Zealand Journal of Psychiatry, vol. 44, no. 5, pp. 469-474. 8 8
2010	Kalisch Ellett, LM, Roughead, EE & Gilbert, AL 2010, 'Improving heart failure outcomes with pharmacist-physician collaboration : how close are we?', Future Cardiology, vol. 6, no. 2, pp. 255-268. 10 3
2010	Kemp, A, Roughead, EE, Preen, D, Glover, J & Semmens, J 2010, 'Determinants of self-reported medicine underuse due to cost : a comparison of seven countries', Journal of Health Services Research and Policy, vol. 15, no. 2, pp. 106-114. 56 50
2010	Othman, N, Vitry, A I, Roughead, EE, Ismail, SB & Omar, K 2010, 'Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia', BMC Public Health, vol. 10, article no. 743, pp.1-11. Open access 23 16
2010	Othman, N, Vitry, AI & Roughead, EE 2010, 'Medicines information in medical journal advertising in Australia, Malaysia and the United States: A comparative cross-sectional study', Southern Med Review, vol. 3, no. 1, pp. 11-18. 8
2010	Othman, N, Vitry, AI & Roughead, EE 2010, 'Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States', BMC Public Health, vol. 10, article no. 294. Open access 13 11
2010	Pratt, N, Roughead, EE, Ryan, P & Gilbert, AL 2010, 'Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: A retrospective cohort study', Drugs and Aging, vol. 27, no. 1, pp. 63-71. 20 16
2010	Pratt, N, Roughead, EE, Ryan, P & Salter, A 2010, 'Antipsychotics and the risk of death in the elderly : an instrumental variable analysis using two preference based instruments', Pharmacoepidemiology and Drug Safety, vol. 19, no. 7, pp. 699-707. 26 25
2010	Pratt, N, Roughead, EE, Salter, A & Ryan, P 2010, 'Factors associated with choice of antipsychotic treatment in elderly veterans: potential confounders for observational studies', Australian and New Zealand Journal of Public Health, vol. 34, no. 6, pp. 589-593. 5 5
2010	Pratt, NL, Roughead, EE, Ramsay, E, Salter, A & Ryan, P 2010, 'Risk of hospitalization for stroke associated with antipsychotic use in the elderly : a self-controlled case series', Drugs and Aging, vol. 27, no. 11, pp. 885-893. 29 31
2010	Roughead, EE, Barratt, JD, Ramsay, E, Pratt, N, Ryan, P, Peck, R, Killer, G & Gilbert, AL 2010, 'Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans', Journal of Clinical Pharmacy and Therapeutics.
2010	Roughead, EE, Kalisch Ellett, LM, Barratt, JD & Gilbert, AL 2010, 'Prevalence of potentially hazardous drug interactions amongst Australian veterans', British Journal of Clinical Pharmacology, vol. 70, no. 2, pp. 252-257. Open access 44 32
2010	Roughead, EE, Kalisch Ellett, LM, Ramsay, EN, Ryan, P & Gilbert, AL 2010, 'Use of health services and medicines amongst Australian war veterans : a comparison of young elderly, near centenarians and centenarians', BMC Geriatrics, vol. 10, article no. 83. Open access 7 3
2010	Roughead, EE, Vitry, AI, Preiss, A, Barratt, JD, Gilbert, AL & Ryan, P 2010, 'Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease', European Journal of Preventative Cardiology, vol. 17, no. 1, pp. 71-76. 11 11
2010	Vitry, A I, Roughead, EE, Preiss, AK, Ryan, P, Ramsay, EN, Gilbert, AL, Caughey, GE, Shakib, S, Esterman, A, Zhang, Y & McDermott, RA 2010, 'Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study', PLoS One, vol. 5, no. 11, article no. e14024. Open access 28 26
2010	Zhang, Y, Chow, V, Vitry, A I, Ryan, P, Roughead, EE, Caughey, GE, Ramsay, EN, Gilbert, AL, Esterman, A & Luszcz, MA 2010, 'Antidepressant use and depressive symptomatology among older people from the Australian longitudinal study of ageing', International Psychogeriatrics, vol. 22, no. 3, pp. 437-444. Open access 20 20
2010	Zhang, Y, Vitry, AI, Roughead, EE, Ryan, P & Gilbert, AL 2010, 'Co-morbidity and the utilization of health care for Australian veterans with diabetes', Diabetic Medicine, vol. 27, no. 1, pp. 65-71. 12 9
2009	Hynd, A, Roughead, EE, Preen, DB, Glover, J, Bulsara, M & Semmens, J 2009, 'Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia', Australian and New Zealand Journal of Public Health, vol. 33 no. 3, pp. 246-252. Open access 21 20
2009	Kalisch Ellett, LM, Roughead, EE & Gilbert, AL 2009, 'Pharmaceutical brand substitution in Australia : identifying factors associated with having multiple brand substitutions', International Journal of Pharmacy Practice, vol. 17, no. 6, pp. 339-344.
2009	Morgan, S, Kennedy, J, Boothe, K, McMahon, M, Watson, D & Roughead, E 2009, 'Toward an understanding of high performance, pharmaceutical policy systems : a "triple-A" framework and example analysis', The Open Health Services and Policy Journal, vol. 2, pp. 1-9. Open access
2009	Othman, N, Vitry, A & Roughead, EE 2009, 'Quality of pharmaceutical advertisements in medical journals : a systematic review', PLoS One, vol. 4, no. 7, article no. e6350, pp. 1-11. Open access 68 52
2009	Roughead, EE & Semple, SJ 2009, 'Medication safety in acute care in Australia : where are we now? Part 1 : a review of the extent and causes of medication problems 2002-2008', Australian Health Review, vol. 6, no. 1, article 18, pp. 1-12. Open access 129
2009	Roughead, EE, Barratt, JD, Ramsay, E, Pratt, N, Ryan, P, Peck, R, Killer, G & Gilbert, AL 2009, 'The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting : results of a cohort study', Circulation: Heart Failure, vol. 2, no. 5, pp. 424-428. Open access 101 76
2009	Roughead, EE, Ramsay, E, Preiss, K, Barratt, J, Ryan, P & Gilbert, AL 2009, 'Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates', Pharmacoepidemiology and Drug Safety, vol. 18, no. 1, pp. 69-75. 16 14
2009	Roughead, EE, Ramsay, EN, Pratt, NL, Ryan, P & Gilbert, AL 2009, 'Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia', Medical Journal of Australia, vol. 190, no. 3, pp. 114-116. 26 17
2009	Semple, SJ & Roughead, EE 2009, 'Medication safety in acute care in Australia: where are we now? Part 2: a review of strategies and activities for improving medication safety 2002-2008', Australian Health Review, vol. 6, article no. 24. Open access 34
2009	Vitry, A, Wong, SA, Roughead, EE, Ramsay, E & Barratt, J 2009, 'Validity of medication-based co-morbidity indices in the Australian elderly population', Australian and New Zealand Journal of Public Health, vol. 33, no. 2, pp. 126-130. Open access 76 73
2008	Caughey, GE, Vitry, AI, Gilbert, AL & Roughead, EE 2008, 'Prevalence of comorbidity of chronic diseases in Australia', BMC Public Health, vol. 8, article no. 221. Open access 141 121
2008	Hughes, C, Roughead, EE & Kerse, N 2008, 'Improving Use of Medicines for Older People in Long-Term Care: Contrasting the Policy Approach of Four Countries', Healthcare Policy, vol. 3, no. 3, pp. 154-167. Open access
2008	Hynd, A, Roughead, EE, Preen, D, Glover, J, Bulsara, M & Semmens, J 2008, 'The impact of co-payment increases on dispensings of government-subsidised medicines in Australia', Pharmacoepidemiology and Drug Safety, vol. 17, no. 11, pp. 1091-1099. 70 66
2008	Kalisch, LM, Roughead, EE & Gilbert, AL 2008, 'Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia', Pharmacoepidemiology and Drug Safety, vol. 17, no. 6, pp. 620-625. 13 9
2008	Morden, N, Zerzan, J, Rue, TC, Heagerty, PJ, Roughead, EE, Soumerai, S, Ross-Degnan, D & Sullivan, S 2008, 'Medicaid Prior Authorization and Controlled-Release Oxycodone', Medical Care, vol. 46, no. 6, pp. 573-580. 26 25
2008	Roughead, EE, Barratt, JD, Gilbert, AL, Peck, R & Killer, G 2008, 'Diabetes processes of care in the Australian veteran population', Diabetes Research and Clinical Practice, vol. 79, no. 2, pp. 299-304. 7 7
2008	Roughead, EE, Gilbert, AL & Vitry, AI 2008, 'The Australian funding debate on quadrivalent HPV vaccine: A case study for the national pharmaceutical policy', Health Policy, vol. 88, no. 2-3, pp. 250-257. 23 21
2008	Roughead, EE, Gilbert, AL & Woodward, MC 2008, 'Medication use by Australian war veterans in residential aged-care facilities', Journal of Pharmacy Practice and Research, vol. 38, no. 1, pp. 14-18. 14
2008	Roughead, EE, Ramsay, E, Pratt, N & Gilbert, AL 2008, 'NSAID Use in individuals at risk of renal adverse events: An observational study to investigate trends in Australian veterans', Drug Safety, vol. 31, no. 11, pp. 997-1003. Open access 17 15
2008	Roughead, EE, Semmens, J, Preen, D, Hynd, A & Glover, J 2008, 'Rising co-payments comes at a huge cost', Australian Journal of Pharmacy, vol. 89 no. 1064, pp. -.

Reports

Year	Output
2020	Lim, R, Semple, S, Kalisch Ellett, L & Roughead, L 2020, Medicine safety: aged care, Pharmaceutical Society of Australia, Australia. Open access
2019	Lim, R, Semple, S, Kalisch Ellett, L & Roughead, L 2019, Medicine safety: take care, Pharmaceutical Society of Australia, Australia. Open access
2018	Roughead, L, Kemp-Casey, A, Pratt, N & Nguyen, TA 2018, Methods to analyse medicine utilization and expenditure to support pharmaceutical policy implementation, World Health Organisation. Open access
2017	Roughead, L, Procter, N, Westaway, K, Sluggett, J & Alderman, C 2017, Medication safety in mental health, Australian Commission on Safety and Quality in Health Care, Australia. Open access
2016	Vitry, A, Nguyen, T, Roughead, E, Baer, B, Bhushan, A & Tisocki, K 2016, Older people's access to medicines and assistive in the Western Pacific Region, World Health Organization, Western Pacific Region, Switzerland. Open access

Other outputs

Medicine Safety: Take Care

Methods to analyse medicine utilization and expenditure to support pharmaceutical policy implementation: WHO

Medication safety in acute care in Australia: where are we now? Part 1, Part 2

Second National Report on Patient Safety – Improving Medication Safety

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Advanced Digital Sciences Center	SINGAPORE
Astellas Pharma	JAPAN
Asthma Australia	AUSTRALIA
Asthma Australia Ltd	AUSTRALIA
Asthma SA	AUSTRALIA
Austin Health	AUSTRALIA
Australian Health Practitioner Regulation Agency	AUSTRALIA
Australian National University	AUSTRALIA
Australian Orthopaedic Association	AUSTRALIA
Bond University	AUSTRALIA
Bupa Health Foundation (formerly MBF Foundation)	AUSTRALIA
Chonnam National University	KOREA, REPUBLIC OF (SOUTH)
Curtin University	AUSTRALIA
Cyberjaya University College of Medical Sciences	MALAYSIA
Deakin University	AUSTRALIA
Department of Health	AUSTRALIA
Department of Health - NSW	AUSTRALIA
Department of Health and Ageing	AUSTRALIA
Department of Health, Manila	PHILIPPINES
Department of Veterans Affairs	AUSTRALIA
Duke Clinical Research Institute	UNITED STATES
Duke University	UNITED STATES
Flinders University	AUSTRALIA
Hamamatsu University	JAPAN
Hanoi Medical University	VIET NAM
Harvard University	UNITED STATES
Health Canada	CANADA
Health Insurance Review and Assessment Service	KOREA, REPUBLIC OF (SOUTH)
Health Sciences Authority	SINGAPORE
Helping Hand Aged Care	AUSTRALIA
Helping Hand Organisation	AUSTRALIA
Hornsby Ku-ring-gai Hospital	AUSTRALIA
Iranian Ministry of Health and Medical Education	IRAN
Jewish General Hospital	CANADA
Kaiser Permanente	UNITED STATES
Karolinska Institute	SWEDEN
Korea Institute of Drug Safety and Risk Management	KOREA, REPUBLIC OF (SOUTH)
Macquarie University	AUSTRALIA
Mahidol University	THAILAND
Mater Public Hospital	AUSTRALIA
McGill University	CANADA
Medicines Information Service	AUSTRALIA
Ministry Health	UNITED STATES
Ministry of Health	IRAQ
Ministry of Health, Malaysia	MALAYSIA
Ministry of Public Health	THAILAND
Monash University	AUSTRALIA
Monash University Malaysia	MALAYSIA
Naresuan University	THAILAND
National Cheng Kung University	TAIWAN
National Cheng Kung University Hospital	TAIWAN
National Geriatric Hospital of Vietnam	VIET NAM
National Prescribing Service	AUSTRALIA
National University of Malaysia	MALAYSIA
Nihon University	JAPAN
niversity of Notre Dame	UNITED STATES
NPO Drug Safety Research Unit	JAPAN
NPS Better Choices Better Health	AUSTRALIA
NPS MedicineWise	AUSTRALIA
Parliament House, Canberra	AUSTRALIA
Pharmacy Improvement Centre Ltd, Welland	AUSTRALIA
Private Individual	AUSTRALIA
Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences	AUSTRALIA
Queen's University	CANADA
Royal Adelaide Hospital	AUSTRALIA
Royal Children's Hospital, Victoria	AUSTRALIA
Royal Perth Hospital	AUSTRALIA
Rutgers University	UNITED STATES
Seoul National University	KOREA, REPUBLIC OF (SOUTH)
Sichuan University	CHINA
South Australian Department of Health	AUSTRALIA
South Australian Health and Medical Research Institute (SAHMRI)	AUSTRALIA
Southern Cross Care (SA)	AUSTRALIA
Sung Kyun Kwan University	KOREA, REPUBLIC OF (SOUTH)
Swedish Hip Arthroplasty Register	SWEDEN
Syddansk Universitet	DENMARK
Taibah University	SAUDI ARABIA
Tehran University of Medical Sciences	IRAN
Telethon Institute for Child Health Research	AUSTRALIA
The University of Notre Dame Australia	AUSTRALIA
Ubon Ratchathani University	THAILAND
Universiti Kabangsaan Malaysia	MALAYSIA
University College London	UNITED KINGDOM
University of Aberdeen	UNITED KINGDOM
University of Adelaide	AUSTRALIA
University of British Columbia	CANADA
University of California, Berkeley	UNITED STATES
University of California, Los Angeles	UNITED STATES
University of Hong Kong	HONG KONG
University of Illinois at Urbana-Champaign	UNITED STATES
University of Melbourne	AUSTRALIA
University of Montreal	CANADA
University of New South Wales	AUSTRALIA
University of Newcastle	AUSTRALIA
University of Queensland	AUSTRALIA
University of Science, Malaysia	MALAYSIA
University of South Australia	AUSTRALIA
University Of South Carolina - Columbia	UNITED STATES
University of Sydney	AUSTRALIA
University of Tasmania	AUSTRALIA
University of Technology Sydney	AUSTRALIA
University of Tokyo	JAPAN
University of Toronto	CANADA
University of Utah	UNITED STATES
University of Washington	UNITED STATES
University of Western Australia	AUSTRALIA
University of Wollongong	AUSTRALIA
University School of Medicine	UNITED STATES
Utrecht University (AKA Hogeschool Utrecht)	NETHERLANDS
Veterans’ Medicines Advice and Therapeutics Education Services (Veterans’ MATES)	AUSTRALIA
Washington State University	UNITED STATES
Women's and Children's Hospital	AUSTRALIA
World Health Organisation	SWITZERLAND
York University	CANADA

External engagement & recognition

Engagement/recognition	Year
Invited Speaker - Medication safety in aged-care: our role and responsibility ConPharm Australian Association of Consultant Pharmacists	2020
Invited Speaker - Medication Safety: Do no harm Central Adelaide Health Network	2020
Invited speaker - People Improving the Use of Medicines: What We Know and Don't Know International Society for Improving Use of Medicines	2020
Invited speaker at conference International Society for Pharmacovigilance	2020
Member of an advisory board - Research and Evaluation Reference Group Australian Digital Health Agency	2020
Plenary speaker - Initiatives to improve the use of medicines: Australia's experience People, purpose, passion: the pathway to success for rational drug use country. Side meeting of the Prince Mahidol Awards Conference	2020
Advisory Board Member Australian Centre of Excellence for Post Traumatic Stress	2019
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2019
Drug Utilisation Sub Committee of the Pharmaceutical Benefits Advisory Committee Member Department of Health	2019
Editorial Board Member Drug Safety Case Reports	2019
Fellow International Society of Pharmacoepidemiology	2019
Member International Society for Pharmacovigilance	2019
Member Australasian Pharmaceutical Sciences Association	2019
Member Health Services Research Association Australian and New Zealand	2019
Research Australia University Roundtable Invited Speaker Research Australia	2019
Safety and Quality Committee Member Australian Digital Health Agency	2019
Senior Principle Research Fellowship National Health and Medical Research Council	2019
Winner - The Health Services Award Research Australia	2019
Advisory Board Member Australian Centre of Excellence for Post Traumatic Stress	2018
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2018
Editorial Board Member Drug Safety Case Reports	2018
Fellow International Society of Pharmacoepidemiology	2018
Member International Society for Pharmacovigilance	2018
Member: Advisory Committee Australian Centre of Excellence for Post Traumatic Stress	2018
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2018
Safety and Quality Committee Member Australian Digital Health Agency	2018
Senior Principle Research Fellowship National Health and Medical Research Council	2018
Working Group on using antimicrobial consumption data at country level - temporary advisor World Health Organisation	2018
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2017
Director Quality Use of Medicines and Pharmacy Research Centre	2017
Distinguished investigator Award: Lifetime Achievement Health Services Research Australia and New Zealand	2017
Distinguished Investigator Life Time Achievement Award Health Services Research Association Australia and New Zealand (HSRAANZ)	2017
Editorial Board Member Drug Safety Case Reports	2017
Fellow International Society of Pharmacoepidemiology	2017
Fellow International Society of Pharmacoepidemiology (ISPE)	2017
Member International Society for Pharmacovigilance	2017
Member International Society of Pharmacovigilance (ISOP)	2017
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2017
Program Leader Veterans Medicines Advice and Therapeutics Education Services - (V)MATES, Australian Government	2017
Safety and Quality Committee Member Australian Digital Health Agency	2017
Senior Principal Research Fellow Health Services Research Association Australia and New Zealand (HSRAANZ)	2017
Senior Principle Research Fellowship National Health and Medical Research Council	2017
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2016
Editorial Board Member Drug Safety Case Reports	2016
Fellow International Society of Pharmacoepidemiology	2016
Member International Society for Pharmacovigilance	2016
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2016
Senior Principle Research Fellowship National Health and Medical Research Council	2016
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2015
Editorial Board Member Drug Safety Case Reports	2015
Member International Society for Pharmacovigilance	2015
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2015
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2014
Editorial Board Member Drug Safety Case Reports	2014
Member International Society for Pharmacovigilance	2014
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2014
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2013
Member International Society for Pharmacovigilance	2013
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2013
Associate Editor International Society of Pharmacoepidemiology and Drug Safety	2012
Member International Society for Pharmacovigilance	2012
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2012
Member International Society for Pharmacovigilance	2011
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee Department of Health, Australian Government	2011
Future Fellowship Australian Research Council (ARC)	2010

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Enriching pharmacoepidemiology with molecular similarity approaches in order to support adverse event detection	Current
How do Governments manage uncertainty about pharmaceutical evidence while maintaining a transparent and rigorous decision-making process for public reimbursement of pharmaceuticals?	Current
The cost and health implications of medication shortages in Australia	Current
Developing computational methods for detecting signals of adverse drug events from healthcare data	Completed
Developing data mining methods for detecting signals of adverse drug events	Completed
Enhancing Australia's pharmaco-surveillance capacity: a validation of sequence symmetry analysis method	Completed
Fixed dose combination medicine use in cardiovascular disease: implications for quality use of medicines and subsidy in Australia	Completed
Medicines and the risk of hip fracture among older people: an investigation of medicine safety in administrative claims data	Completed
Quality of information in pharmaceutical promotion	Completed
Targeting medicines in the prevention of delirium in older patients: a principal role for pharmacists	Completed
Understanding frailty and its association with medicine use	Completed

Professor Libby Roughead

Alternative contact

Alternative contact details

About me

About me

UniSA Clinical & Health Sciences

Other UniSA associations

About me

Professional Associations

In the media

Experience

Qualifications

Research

Research themes

Research focus

Highlights

Projects

Other projects

Outputs

Highlights

Chapters

Journal Articles

Reports

Other outputs

Current research & highlights

External engagement & recognition

Collaborations

Collaborations

External engagement & recognition

Invited Speaker - Medication safety in aged-care: our role and responsibility

Invited Speaker - Medication Safety: Do no harm

Invited speaker - People Improving the Use of Medicines: What We Know and Don't Know

Invited speaker at conference

Member of an advisory board - Research and Evaluation Reference Group

Plenary speaker - Initiatives to improve the use of medicines: Australia's experience

Advisory Board Member

Associate Editor

Drug Utilisation Sub Committee of the Pharmaceutical Benefits Advisory Committee Member

Editorial Board Member

Fellow

Member

Member

Member

Research Australia University Roundtable Invited Speaker

Safety and Quality Committee Member

Senior Principle Research Fellowship

Winner - The Health Services Award

Advisory Board Member

Associate Editor

Editorial Board Member

Fellow

Member

Member: Advisory Committee

Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee

Safety and Quality Committee Member

Senior Principle Research Fellowship

Working Group on using antimicrobial consumption data at country level - temporary advisor

Associate Editor

Director

Distinguished investigator Award: Lifetime Achievement

Distinguished Investigator Life Time Achievement Award

Editorial Board Member

Fellow

Fellow

Member

Member

Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee

Program Leader

Safety and Quality Committee Member

Senior Principal Research Fellow

Senior Principle Research Fellowship

Associate Editor

Editorial Board Member

Fellow

Member

Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee

Senior Principle Research Fellowship

Associate Editor

Editorial Board Member

Member